BioPharma Dive - Latest News

Bayer braces for ‘difficult’ year before turnaround pays dividends

CEO Bill Anderson warned investors that profits will decline in 2025 before the company’s ongoing shake-up leads to an “improved trajectory” next year. 

Mar 5, 2025 - 17:55
 0
Bayer braces for ‘difficult’ year before turnaround pays dividends

CEO Bill Anderson warned investors that profits will decline in 2025 before the company’s ongoing shake-up leads to an “improved trajectory” next year. 

Read More

Tags:

Previous Article

Jazz expands in oncology with $935M deal for Chimerix

Next Article

Defective 1T-VS2 with Fibonacci Pattern Unlocking High Mass-Loading and Self-Cha...

Related Posts

FTC retains stricter merger guidelines under Trump

FTC retains stricter merger guidelines under Trump

Feb 19, 2025  0

Novartis pays $925M to reel in a startup it helped launch

Novartis pays $925M to reel in a startup it helped launch

Feb 11, 2025  0

Pfizer names Patrizia Cavazzoni, former top FDA official, as chief medical officer

Pfizer names Patrizia Cavazzoni, former top FDA officia...

Feb 24, 2025  0